2m 2m 2m 2m 2m 2m 2m
MAR LFSCI HLDG-A (MRVI)
NASDAQ
$7.91+$0.21 (+2.73%)
Price as of Nov 12, 2026 9:05 AM EST- $1.1BMarket Cap
- 136.92%1-Year Change
- BiotechnologyIndustry
MAR LFSCI HLDG-A (MRVI)
$7.91+$0.21 (+2.73%)
MRVI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.70 | ||
Change | -$0.16 (-2.04%) | ||
Open | $7.96 | ||
High | $8.18 | ||
Low | $7.68 | ||
Previous Close | $7.86 | ||
Volume | 2,036,772 | ||
30-Day Average Volume | 2,188,827 | ||
1-Week Change | -0.26% | ||
1-Month Change | 3.49% | ||
1-Year Change | 136.92% | ||
3-Year Change | 50.10% | ||
5-Year Change | -78.86% | ||
Fundamentals | |||
Shares Outstanding | 149.3M | ||
Total Assets | $600.1M | ||
Market Cap | $1.1B | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | $45.9M | ||
Net Income | -$13.8M | ||
Free Cash Flow | $4.5M | ||
EBIT | -$13.9M | ||
EBITDA | -$7.4M | ||
Net Working Capital | $120.9M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | -164 | ||
Enterprise Value/Revenue | 27 | ||
P/B | 6 | ||
P/E | -86 | ||
PEG | 7 | ||
Price/Free Cash Flow | 256 | ||
Price/Operating Cash Flow | 229 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue